722 related articles for article (PubMed ID: 34079127)
1. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Correia AL; Guimaraes JC; Auf der Maur P; De Silva D; Trefny MP; Okamoto R; Bruno S; Schmidt A; Mertz K; Volkmann K; Terracciano L; Zippelius A; Vetter M; Kurzeder C; Weber WP; Bentires-Alj M
Nature; 2021 Jun; 594(7864):566-571. PubMed ID: 34079127
[TBL] [Abstract][Full Text] [Related]
2. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis.
Yu PF; Huang Y; Xu CL; Lin LY; Han YY; Sun WH; Hu GH; Rabson AB; Wang Y; Shi YF
Oncogene; 2017 Feb; 36(6):840-849. PubMed ID: 27669436
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy.
Khazali AS; Clark AM; Wells A
Br J Cancer; 2018 Feb; 118(4):566-576. PubMed ID: 29169181
[TBL] [Abstract][Full Text] [Related]
5. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.
Smyth MJ; Cretney E; Takeda K; Wiltrout RH; Sedger LM; Kayagaki N; Yagita H; Okumura K
J Exp Med; 2001 Mar; 193(6):661-70. PubMed ID: 11257133
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation.
Milling LE; Garafola D; Agarwal Y; Wu S; Thomas A; Donahue N; Adams J; Thai N; Suh H; Irvine DJ
Cancer Immunol Res; 2022 Jan; 10(1):26-39. PubMed ID: 34686488
[TBL] [Abstract][Full Text] [Related]
9. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
10. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.
Dewan MZ; Terunuma H; Takada M; Tanaka Y; Abe H; Sata T; Toi M; Yamamoto N
Breast Cancer Res Treat; 2007 Sep; 104(3):267-75. PubMed ID: 17066321
[TBL] [Abstract][Full Text] [Related]
11. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
12. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
[TBL] [Abstract][Full Text] [Related]
13. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
Bahjat KS; Prell RA; Allen HE; Liu W; Lemmens EE; Leong ML; Portnoy DA; Dubensky TW; Brockstedt DG; Giedlin MA
J Immunol; 2007 Dec; 179(11):7376-84. PubMed ID: 18025181
[TBL] [Abstract][Full Text] [Related]
14. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
Taylor DP; Clark A; Wheeler S; Wells A
Breast Cancer Res Treat; 2014 Apr; 144(3):551-60. PubMed ID: 24610032
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
Lan Q; Peyvandi S; Duffey N; Huang YT; Barras D; Held W; Richard F; Delorenzi M; Sotiriou C; Desmedt C; Lorusso G; Rüegg C
Oncogene; 2019 Apr; 38(15):2814-2829. PubMed ID: 30546090
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Dormant Cancer Cells and Their Microenvironment.
Linde N; Fluegen G; Aguirre-Ghiso JA
Adv Cancer Res; 2016; 132():45-71. PubMed ID: 27613129
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.
Akkoc Y; Gozuacik D
J Gastrointest Cancer; 2021 Dec; 52(4):1277-1293. PubMed ID: 34921672
[TBL] [Abstract][Full Text] [Related]
18. Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.
Aqbi HF; Coleman C; Zarei M; Manjili SH; Graham L; Koblinski J; Guo C; Xie Y; Guruli G; Bear HD; Idowu MO; Habibi M; Wang XY; Manjili MH
Breast Cancer Res; 2020 Oct; 22(1):116. PubMed ID: 33115528
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system.
Wheeler SE; Clark AM; Taylor DP; Young CL; Pillai VC; Stolz DB; Venkataramanan R; Lauffenburger D; Griffith L; Wells A
Br J Cancer; 2014 Dec; 111(12):2342-50. PubMed ID: 25314052
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression.
Miller G; Bleier JI; Antonescu C; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
Int J Cancer; 2004 Jun; 110(3):395-402. PubMed ID: 15095305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
